132 related articles for article (PubMed ID: 28462843)
1. Covalent inhibitors of LgtC: A blueprint for the discovery of non-substrate-like inhibitors for bacterial glycosyltransferases.
Xu Y; Smith R; Vivoli M; Ema M; Goos N; Gehrke S; Harmer NJ; Wagner GK
Bioorg Med Chem; 2017 Jun; 25(12):3182-3194. PubMed ID: 28462843
[TBL] [Abstract][Full Text] [Related]
2. Structure-activity relationships in a new class of non-substrate-like covalent inhibitors of the bacterial glycosyltransferase LgtC.
Xu Y; Cuccui J; Denman C; Maharjan T; Wren BW; Wagner GK
Bioorg Med Chem; 2018 Jul; 26(11):2973-2983. PubMed ID: 29602676
[TBL] [Abstract][Full Text] [Related]
3. Novel disaccharide inhibitors for the bacterial galactosyltransferase LgtC: Design, synthesis via Heyns rearrangement, and biochemical evaluation.
Métier CC; Wagner GK
Carbohydr Res; 2020 Jun; 492():108017. PubMed ID: 32402851
[TBL] [Abstract][Full Text] [Related]
4. Crystal structure of the retaining galactosyltransferase LgtC from Neisseria meningitidis in complex with donor and acceptor sugar analogs.
Persson K; Ly HD; Dieckelmann M; Wakarchuk WW; Withers SG; Strynadka NC
Nat Struct Biol; 2001 Feb; 8(2):166-75. PubMed ID: 11175908
[TBL] [Abstract][Full Text] [Related]
5. Nuclear magnetic resonance spectral assignments of α-1,4-galactosyltransferase LgtC from Neisseria meningitidis: substrate binding and multiple conformational states.
Chan PH; Weissbach S; Okon M; Withers SG; McIntosh LP
Biochemistry; 2012 Oct; 51(41):8278-92. PubMed ID: 22992161
[TBL] [Abstract][Full Text] [Related]
6. Covalent Probes for Carbohydrate-Active Enzymes: From Glycosidases to Glycosyltransferases.
Xu Y; Uddin N; Wagner GK
Methods Enzymol; 2018; 598():237-265. PubMed ID: 29306437
[TBL] [Abstract][Full Text] [Related]
7. Molecular modeling insights into the catalytic mechanism of the retaining galactosyltransferase LgtC.
Tvaroska I
Carbohydr Res; 2004 Apr; 339(5):1007-14. PubMed ID: 15010308
[TBL] [Abstract][Full Text] [Related]
8. Intermediate trapping on a mutant retaining alpha-galactosyltransferase identifies an unexpected aspartate residue.
Lairson LL; Chiu CP; Ly HD; He S; Wakarchuk WW; Strynadka NC; Withers SG
J Biol Chem; 2004 Jul; 279(27):28339-44. PubMed ID: 15075344
[TBL] [Abstract][Full Text] [Related]
9. Investigating the structural dynamics of α-1,4-galactosyltransferase C from Neisseria meningitidis by nuclear magnetic resonance spectroscopy.
Chan PH; Cheung AH; Okon M; Chen HM; Withers SG; McIntosh LP
Biochemistry; 2013 Jan; 52(2):320-32. PubMed ID: 23259770
[TBL] [Abstract][Full Text] [Related]
10. Identification of non-substrate-like glycosyltransferase inhibitors from library screening: pitfalls & hits.
Ema M; Xu Y; Gehrke S; Wagner GK
Medchemcomm; 2018 Jan; 9(1):131-137. PubMed ID: 30108907
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of glycosyltransferase activities as the basis for drug development.
Schutzbach J; Brockhausen I
Methods Mol Biol; 2009; 534():359-73. PubMed ID: 19277539
[TBL] [Abstract][Full Text] [Related]
12. Structural analysis of substrate-mimicking inhibitors in complex with Neisseria meningitidis 3-deoxy-d-arabino-heptulosonate 7-phosphate synthase - The importance of accommodating the active site water.
Heyes LC; Reichau S; Cross PJ; Jameson GB; Parker EJ
Bioorg Chem; 2014 Dec; 57():242-250. PubMed ID: 25245459
[TBL] [Abstract][Full Text] [Related]
13. Glycosyltransferase Activity Assay Using Colorimetric Methods.
Shafiqur Rahman M; Qin W
Methods Mol Biol; 2019; 1954():237-243. PubMed ID: 30864136
[TBL] [Abstract][Full Text] [Related]
14. Pasteurella multocida CMP-sialic acid synthetase and mutants of Neisseria meningitidis CMP-sialic acid synthetase with improved substrate promiscuity.
Li Y; Yu H; Cao H; Muthana S; Chen X
Appl Microbiol Biotechnol; 2012 Mar; 93(6):2411-23. PubMed ID: 21968653
[TBL] [Abstract][Full Text] [Related]
15. An acceptor analogue of β-1,4-galactosyltransferase: Substrate, inhibitor, or both?
Jiang J; Wagner GK
Carbohydr Res; 2017 Oct; 450():54-59. PubMed ID: 28910600
[TBL] [Abstract][Full Text] [Related]
16. Efficient chemoenzymatic synthesis of globotriose and its derivatives with a recombinant alpha-(1-->4)-galactosyltransferase.
Zhang J; Kowal P; Fang J; Andreana P; Wang PG
Carbohydr Res; 2002 Jun; 337(11):969-76. PubMed ID: 12039536
[TBL] [Abstract][Full Text] [Related]
17. Pasteurella multocida expresses two lipopolysaccharide glycoforms simultaneously, but only a single form is required for virulence: identification of two acceptor-specific heptosyl I transferases.
Harper M; Boyce JD; Cox AD; St Michael F; Wilkie IW; Blackall PJ; Adler B
Infect Immun; 2007 Aug; 75(8):3885-93. PubMed ID: 17517879
[TBL] [Abstract][Full Text] [Related]
18. Recent structures, evolution and mechanisms of glycosyltransferases.
Breton C; Fournel-Gigleux S; Palcic MM
Curr Opin Struct Biol; 2012 Oct; 22(5):540-9. PubMed ID: 22819665
[TBL] [Abstract][Full Text] [Related]
19. New structures, chemical functions, and inhibitors for glycosyltransferases.
Roychoudhury R; Pohl NL
Curr Opin Chem Biol; 2010 Apr; 14(2):168-73. PubMed ID: 20129812
[TBL] [Abstract][Full Text] [Related]
20. Complete chemoenzymatic synthesis of the Forssman antigen using novel glycosyltransferases identified in Campylobacter jejuni and Pasteurella multocida.
Houliston RS; Bernatchez S; Karwaski MF; Mandrell RE; Jarrell HC; Wakarchuk WW; Gilbert M
Glycobiology; 2009 Feb; 19(2):153-9. PubMed ID: 18955372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
